Supernus Pharmaceuticals Balance Sheet (2011-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)	215.28M	203.43M	115.72M	173.43M	111.49M	93.12M	58.44M	24.71M	94.98M	75.05M	63.40M	52.09M	31.67M	69.33M	115.85M	144.71M	151.37M	128.45M	184.87M	179.95M
Short-term Investments (Quarter)	228.57M	136.25M	196.49M	187.36M	280.30M	368.21M	170.13M	126.95M	105.20M	179.82M	234.34M	295.10M	371.54M	384.28M	347.74M	377.88M	129.79M	180.22M	199.37M	192.11M
Cash & Current Investments (Quarter)	443.85M	339.68M	312.20M	360.79M	391.79M	461.33M	228.57M	151.66M	200.19M	254.87M	297.74M	347.19M	403.21M	453.61M	463.59M	522.60M	281.16M	308.67M	384.24M	372.07M
Receivables - Net (Quarter)	133.68M	148.93M	145.15M	158.06M	164.09M	165.50M	143.57M	136.56M	141.76M		147.73M	152.49M	145.41M	142.08M	145.64M	140.83M	171.25M	187.80M	182.18M	211.66M
Receivables - Other (Quarter)														4.00M		5.40M	6.30M	1.80M	1.90M	4.30M
Receivables (Quarter)	133.68M	148.93M	145.15M	158.06M	164.09M	165.50M	143.57M	136.56M	141.76M		147.73M	152.49M	145.41M	146.08M	145.64M	146.23M	177.55M	189.60M	184.08M	215.96M
Raw Materials (Quarter)	9.71M	7.33M	9.24M	7.46M	11.01M	24.82M	22.92M	28.16M	21.56M	16.27M	18.80M	15.90M	11.57M	11.13M	8.66M	8.42M	56.99M	31.83M	31.47M	22.96M
Work In Process (Quarter)	37.91M	45.71M	46.22M	36.86M	25.46M	31.71M	33.98M	23.59M	26.97M	31.21M	23.25M	23.59M	28.10M	26.73M	18.69M	15.65M	33.41M	29.44M	36.05M	27.16M
Finished Goods (Quarter)	12.54M	32.92M	33.34M	40.54M	46.69M	35.01M	34.26M	38.81M	34.96M	29.92M	33.03M	28.67M	24.31M	16.44M	22.07M	19.95M	16.70M	21.12M	19.54M	33.80M
Inventory (Quarter)	60.16M	85.96M	88.80M	84.86M	83.17M	91.54M	91.15M	90.56M	83.48M	77.41M	75.08M	68.16M	63.98M	54.29M	49.42M	44.02M	79.40M	82.39M	87.06M	83.92M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	30.69M	27.02M	22.37M	21.41M	24.85M	15.78M	16.30M	44.77M	23.93M	16.68M	23.77M	23.17M	27.40M	36.09M	28.93M	31.42M	62.08M	65.33M	78.09M	55.85M
Current Assets (Quarter)	668.38M	601.59M	568.52M	625.12M	663.89M	734.15M	883.34M	423.54M	449.36M	493.11M	544.32M	591.00M	640.00M	686.07M	687.58M	738.87M	593.89M	644.18M	731.58M	723.50M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	16.47M	16.95M	17.21M	16.32M	15.87M	15.17M	14.61M	14.19M	13.69M	13.53M	12.97M	12.27M	11.88M	11.54M	11.34M	11.07M	10.63M	10.53M	10.04M	10.20M
Long-Term Investments (Quarter)	405.48M	119.17M	125.34M	147.37M	131.94M	93.90M	54.16M	37.48M	25.12M	16.62M	11.66M
Goodwill (Quarter)	77.96M	117.52M	115.41M	115.41M	117.38M	117.02M	117.02M	117.02M	117.02M	117.02M	117.02M	117.02M	117.02M	117.02M	117.02M	117.02M	119.08M	124.88M	120.67M	119.43M
Intangibles (Quarter)	346.62M	784.69M	764.05M	743.40M	722.76M	702.46M	682.50M	662.39M	641.15M	599.89M	579.75M	559.64M	540.16M	521.91M	502.13M	481.31M	623.48M	569.46M	549.71M	469.46M
Goodwill & Intangibles (Quarter)	424.58M	902.21M	879.46M	858.82M	840.14M	819.48M	799.52M	779.41M	758.17M	716.91M	696.77M	676.66M	657.17M	638.93M	619.14M	598.33M	742.56M	694.34M	670.38M	588.89M
Long-Term Deferred Tax (Quarter)																6.18M	8.79M	38.35M	30.82M	49.06M
Other Non-Current Assets (Quarter)	40.13M	49.23M	48.99M	47.34M	41.29M	39.81M	403.76M	38.49M	38.82M		38.37M	35.89M		31.53M		27.96M	1.45M	1.45M	56.45M	55.02M
Non-Current Assets (Quarter)	886.66M	1,087.56M	1,071.00M	1,069.85M	1,029.24M	968.36M	908.47M	869.56M	835.80M	784.56M	759.77M	724.83M	702.70M	682.00M	659.71M	643.54M	825.86M	808.47M	769.14M	704.61M
Assets (Quarter)	1,555.04M	1,689.15M	1,639.52M	1,694.97M	1,693.13M	1,702.51M	1,791.81M	1,293.10M	1,285.16M	1,277.67M	1,304.09M	1,315.83M	1,342.70M	1,368.07M	1,347.29M	1,382.40M	1,419.75M	1,452.65M	1,500.72M	1,428.11M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	72.29M	117.68M	89.43M	133.00M	110.30M	96.34M	95.34M	83.04M	78.47M	79.57M	86.40M	82.61M	75.80M	76.35M	76.89M	77.74M	108.61M	107.80M	101.24M	108.46M
Notes Payables (Quarter)						401.97M	402.50M
Payables (Quarter)	72.29M	117.68M	89.43M	133.00M	110.30M	498.31M	497.85M	83.04M	78.47M	79.57M	86.40M	82.61M	75.80M	76.35M	76.89M	77.74M	108.61M	107.80M	101.24M	108.46M
Accumulated Expenses (Quarter)	132.05M	117.68M	140.18M	145.76M	110.30M	96.34M	147.85M	83.04M	162.47M	79.57M	167.23M	82.61M	169.12M	76.35M	170.13M	77.74M	184.46M	107.80M	101.24M	198.84M
Other Accumulated Expenses (Quarter)	6.81M	20.13M	8.05M	8.63M	8.19M	16.86M	7.49M		0.71M	4.28M	9.55M	3.62M			4.75M	27.70M	26.32M	38.22M	82.97M	40.08M
Short term Debt (Quarter)	23.57M	44.84M	46.89M	47.24M	47.59M	21.12M	78.36M	20.72M	45.88M	52.07M	51.38M	47.30M	46.58M	47.34M	30.00M		11.23M	31.05M
Current Leases (Quarter)
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	234.71M	315.38M	284.56M	735.54M	725.99M	687.96M	731.54M	252.59M	287.53M	290.20M	314.55M	308.66M	291.51M	292.40M	281.77M	286.36M	330.63M	338.17M	373.93M	347.38M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)		379.25M
Convertible Debt (Quarter)	374.79M	379.25M	400.38M
Non-Current Deffered Revenue (Quarter)
Pension (Quarter)
Non-Current Deferred Tax Liability (Quarter)	34.15M	85.36M	62.84M	59.31M	58.16M	184.68M	49.67M	44.30M	35.22M	156.27M	19.50M	11.44M	7.36M	4.96M	0.98M			161.50M
Operating Leases (Quarter)	43.16M	41.30M	46.03M	44.12M	36.03M	36.00M	44.09M	42.20M	33.84M	41.53M	32.99M	30.29M	38.15M	34.27M	26.37M	24.38M	31.42M	40.98M	40.90M	40.17M
Other Non-Current Liabilities (Quarter)	18.19M	80.48M	14.14M	11.96M	9.78M	8.69M	53.32M	8.73M	53.65M	6.42M	6.90M	48.00M	0.40M		7.46M		0.21M	22.19M	0.21M	19.87M
Total Non-Current Liabilities (Quarter)	726.39M	792.82M	796.93M	841.57M	830.55M	807.61M	826.34M	364.46M	319.31M	349.74M	368.02M	310.38M	335.15M	332.34M	309.12M	318.50M	369.87M	368.74M	423.71M	377.01M
Total Liabilities (Quarter)	744.57M	873.30M	811.07M	853.54M	840.33M	816.30M	879.66M	373.19M	372.97M	356.16M	374.92M	358.38M	335.55M	332.34M	316.58M	318.50M	370.09M	390.93M	423.92M	396.88M
Shareholder's Equity
Total Debt (Quarter)	23.57M	424.09M	46.89M	47.24M	47.59M	21.12M	78.36M	20.72M	45.88M	52.07M	51.38M	47.30M	46.58M	47.34M	30.00M		11.23M	31.05M
Common Equity (Quarter)	810.47M	815.85M	828.45M	841.43M	852.80M	886.20M	912.15M	919.91M	912.19M	921.52M	929.17M	957.45M	1,007.15M	1,035.73M	1,030.70M	1,063.90M	1,049.67M	1,061.71M	1,076.81M	1,031.23M
Liabilities and Shareholders Equity (Quarter)	1,555.04M	1,689.15M	1,639.52M	1,694.97M	1,693.13M	1,702.51M	1,791.81M	1,293.10M	1,285.16M	1,277.67M	1,304.09M	1,315.83M	1,342.70M	1,368.07M	1,347.29M	1,382.40M	1,419.75M	1,452.65M	1,500.72M	1,428.11M
Retained Earnings (Quarter)	377.48M	434.34M	446.15M	454.01M	401.03M	481.25M	416.23M	-1.77M	431.96M	439.49M	446.96M	502.60M	541.10M	479.44M	544.60M	496.95M	527.70M	517.88M	-0.26M	574.09M
Preferred Shares (Quarter)
Treasury Shares (Quarter)	0.02M	0.05M	0.13M	0.13M	0.22M	0.18M	0.17M	0.02M	0.31M	0.27M	0.40M	0.43M	0.38M	0.32M	0.20M	0.42M	0.40M	0.39M	0.36M	0.35M

Research Tools

Datasets

Plans

Developers

Supernus Pharmaceuticals SUPN Balance Sheet (2011-2026)

Research Tools

Datasets

Plans

Developers

Supernus Pharmaceuticals SUPN Balance Sheet (2011-2026)

Create an account

Sign In

Reset Password